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Based on the study of the physical properties of the tabletting mass the choice of excipients for 
“Corvalol” sublingual tablets by the method of direct compression has been substantiated. Three 
model mixtures for tablet formulations have been analyzed. It has been found that the optimal ex-
cipients are β-cyclodextrin, lactose monohydrate 80, potassium acesulfame, magnesium stearate. It has 
been demonstrated that the conclusions made when analysing physical parameters of the tablet 
formulations are confirmed by actual results of compression.
Sublingual tablets are convenient for the elderly and 
patients with swallowing problems. This form is also 
indispensable in emergency situations when it is neces-
sary to take the drug immediately, and drinking liquids 
are not available. Usually the small volume of saliva 
is enough to dissolve such tablets completely. Active 
substances of the tablet enter the blood flow, sucked by 
the sublingual mucosa directly, or can be swallowed as 
a solution, followed by absorption in the mucosa of the 
gastrointestinal tract. By sublingual administration of 
active substances the therapeutic effect is faster than by 
oral administration because the drug enters the blood 
flow by avoiding the primary metabolism in the patient’s 
liver [1-3].
“Corvalol” drops are indispensable for more than 50 
years for the functional disorders of the nervous system, 
disorders of the autonomic nervous system, diseases of 
the cardiovascular system, spastic pain [4]. In the modern 
world solid dosage forms have become increasingly po- 
pular by displacing liquid forms. This makes develop-
ment of a drug in tablets similar to “Corvalol” drops 
promising.
There are many ways for obtaining fast dissolving 
or fast disintegrating tablets [5, 6]. One of them is the 
direct compression method, which requires introduction 
of an effective disintegrator in the tablet formulation or 
the use of fast dissolving components. The method does 
not require the use of water or heating during formu-
lation, and it is optimal for active substances that are 
unstable in water or thermolabile ingredients. However, 
this method is very sensitive to the type and proportion 
of excipients in the tablet composition [7].
The aim of this work was to carry out the experi-
mental studies on choosing excipients and their amounts 
for obtaining “Corvalol” in the form of sublingual fast 
dissolving tablets by the method of direct compression.
Materials and Methods
The following components were used: β-cyclodextrin 
(“ISP” GmbH, Switzerland), ethyl ester of α-bromo-
isovaleric acid (“Farmak” PJSC, Ukraine), mint oil 
(“Frey + Lau” GmbH, Germany), phenobarbital (“Harman 
Finochem” Ltd., India), potassium acesulfame (“Nutri- 
nova” GmbH, Germany), magnesium stearate (“Trialon” 
Research and Production Company, Ukraine), lactose 
monohydrate 80 (“Merck” GmbH, Germany) , lactose 
monohydrate 200 (“Merck” GmbH, Germany) and sor- 
bitol (“Merck” GmbH, Germany). All substances cor-
responded to the SPhU requirements and were used 
without further purification.
Samples preparation: Complexes of β-cyclodextrin 
with ethyl ester of α-bromo-isovaleric acid and β-cyclo- 
dextrin with mint oil were prepared according to the 
procedure described in [8]. Tablet formulations were 
prepared using a mixer by stepwise mixing of the com-
ponents in the container.
Samples of tablet formulations were prepared by using 
a Glatt CML-10 mixer. Fluidity, the angle of repose and 
the bulk density of the samples obtained were measured 
by an Erweka instrument. Compression of tablet formu-
lations was carried out on a Korsch XL100 press.
Results and Discussion
Special attention was paid to the choice of fast dis-
solving components in the aqueous medium, the use of 
which would make it possible to obtain a tablet formu-
lation that is suitable for obtaining tablets by direct comp- 
ression. Fluidity of such tablet formulation must be higher 
than three grams per second; otherwise, the tablet for-
mulation will stay in the product pipeline of the press. 
The tablet obtained should have smooth edges and a sur-
face without roughness. The bulk density and the angle 
of repose are informative values.
Ethyl ester of α- bromo-isovaleric acid and mint oil 
under normal conditions were converted to a solid form 
by forming the complexes of inclusion with β-cyclodextrin. 
Potassium acesulfame was selected as a sweetener to 
correct the organoleptic properties of tablets. Magne-
sium stearate was used as a lubricant to avoid sticking 
of the mixture for tabletting to the punches of the press. 
The weight of the active ingredients in a tablet was cho-
sen in such a way that one tablet corresponded to ten 
drops of “Corvalol”. The content of the components of the 
model mixtures for tablet formulations are shown in Tab. 1.
By stepwise mixing of the components three vari-
ants of mixtures for tabletting were obtained, in which 
fluidity, the angle of repose and the bulk density were 
determined. The results are shown in Tab. 2.
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The results obtained demonstrate that tablet formu-
lations 1 and 3 are suitable for preparing a tablet by 
direct compression, and the tablet formulation 2 is not 
suitable because of its low fluidity. 
For further selection the compression of all three tab-
let formulations obtained was conducted. The compres-
sion of the tablet formulation 1 was good; the tablets ob-
tained were smooth with no visible chips and roughness. 
The tablet formulation 2 was poorly supplied to the pro-
duct pipelines of the press and, as a result, tablets were 
obtained with no visible chips and roughness, but their 
mass was not homogeneous. Tablets obtained by com-
pression of the tablet formulation 3 had visible chips. 
These observations confirm the conclusions made when 
analysing physical parameters of the tablet formulations. 
CONCLUSIONS
1. The experimental substantiation for the choice of 
excipients of “Corvalol” drug for obtaining the fast dis-
solving sublingual tablets by direct compression has been 
carried out.
2. The technological parameters of three variants of 
tablet formulations for tabletting have been studied. It 
has been demonstrated that the optimal excipients are 
β-cyclodextrin, lactose monohydrate, potassium acesul-
fame, magnesium stearate.
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ОБҐРУНТУВАННЯ ВИБОРУ ДОПОМІЖНИХ КОМПОНЕНТІВ ПРЕПАРАТУ «КОРВАЛОЛ» 
У ФОРМІ СУБЛІНГВАЛЬНИХ ТАБЛЕТОК
І.О.Омельченко, Т.Г.Ярних, Г.І.Борщевський 
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На основі вивчення фізичних властивостей маси для таблетування обґрунтований вибір до-
поміжних речовин для отримання сублінгвальних таблеток «Корвалол» методом прямого 
пресування. Були проаналізовані три модельні суміші для таблетування. Встановлено, що 
оптимальними допоміжними речовинами є β-циклодекстрин, лактози моногідрат 80, аце-
сульфам калію, магнію стеарат. Показано, що висновки, зроблені під час аналізу фізичних па-
раметрів сумішей, підтверджуються фактичними результатами пресування.
ОБОСНОВАНИЕ ВЫБОРА ВСПОМОГАТЕЛЬНЫХ КОМПОНЕНТОВ ПРЕПАРАТА 
«КОРВАЛОЛ» В ФОРМЕ СУБЛИНГВАЛЬНЫХ ТАБЛЕТОК
И.О.Омельченко, Т.Г.Ярных, Г.И.Борщевский
Ключевые слова: Корвалол; таблетки сублингвальные; прямое прессование
На основе изучения физических свойств массы для таблетирования обоснован выбор вспомога-
тельных веществ для получения сублингвальных таблеток «Корвалол» методом прямого прес-
сования. Были проанализированы три модельные смеси для таблетирования. Установлено, что 
оптимальными вспомогательными веществами являются β-циклодекстрин, лактозы моноги-
драт 80, ацесульфам калия, магния стеарат. Показано, что выводы, сделанные при анализе 
физических параметров смесей, подтверждаются фактическими результатами прессования.
Table 1
Model mixtures for tablet formulations  
of “Corvalol” sublingual tablets
The name of the 
component
The content of the 
components in the mixture, %
Mixture 1 Mixture 2 Mixture 3
Ethyl ester of α-bromo-
isovaleric acid 3.10 3.10 3.10
Mint oil 0.22 0.22 0.22
Phenobarbital 2.83 2.83 2.83
β-cyclodextrin 21.44 21.44 21.44
Lactose monohydrate 71.31 – –
Lactose monohydrate – 71.31 –
Sorbitol – – 71.31
Potassium acesulfame 0.10 0.10 0.10
Magnesium stearate 1.00 1.00 1.00
Table 2
Physical parameters of tablet formulations







Tablet formulation 1 3.8 0.15 32 
Tablet formulation 2 1.8 0.09 35 
Tablet formulation 3 3.0 0.16 31 
